Given a document, generate a short title of the document. The title should convey the main idea/event/topic about which the document is being written. Note that URLs in the text have been replaced with [Link].

[EX Q]: Catalan President Carles Puigdemont  said  he  favored mediation to find a way out of the crisis but that Spainâs central government had rejected this. Prime Minister Mariano Rajoyâs government responded by calling on Catalonia to âreturn to the path of lawâ first before any negotiations.
 Puigdemont  told the BBC  he  would ask the regionâs parliament to declare independence following the referendum  which Spainâs government and constitutional court say was illegal and in which only a minority of Catalans voted.
In a televised address on Wednesday night   Puigdemont  said: âThis moment calls for mediation. We have received various offers in the last hours and we will receive more.â
Without specifically mentioning plans for an independence declaration   he  added: âI am sure that in the next few days we will show the best of our country when the institutions of Catalonia will have to apply the results of the referendum.
Prime Minister Mariano Rajoyâs government replied that  Puigdemont  had wasted an opportunity to put Catalonia back on a legal course. âIf  Mr. Puigdemont  wants to talk or negotiate  or wants to send mediators   he  knows perfectly well what  he  must do first: Return to the path of the law â it said in a statement.
 Puigdemont  criticized Spainâs King Felipe VI who on Tuesday lambasted the âirresponsible behaviorâ of the Catalan leaders.
 He  said  the king  had disappointed many people in Catalonia by failing to call for dialogue and  he  accused King Felipe of endorsing the policies of Rajoy  which  he  said had been âcatastrophicâ for Catalonia.
Catalan Regional President Carles Puigdemont gestures as  he  makes an statement at Generalitat Palace in Barcelona  Spain  October 4  2017. Catalan Goverment/Jordi Bedmar Handout via REUTERS
[EX A]: Catalonia moves to declare independence from Spain on Monday

[EX Q]: Former President George W. Bush will be honored at West Point next week , according to a press release from the military academy . 
Bush will be presented the award at a dinner ceremony Thursday , Oct. 19 , hosted by the U.S. Military Academy 's Association of Graduates following a parade open to the public . 
Bush , 71 , will be presented the Thayer Award , which recognizes individuals whose service for the country reflects West Point 's motto of "Duty , Honor , Country ."
[EX A]: George W. Bush to be honored at West Point . 

[EX Q]: A few years ago he began working with Dr. Jenny Chang  medical director of the Lester and Sue Smith Breast Center at Baylor College of Medicine.
 Chang had performed a number of biopsies on breast cancer patients  both on those whose cancers were confined to the breast and on those whose cancers had metastasized to the brain.
 From those biopsies  Chang said she had identified a number of genetic pathways ways in which gene mutations affected the ability of the cancer to spread unique to patients who developed metastatic breast cancer.
 "But I had a lot of trouble with the data and trying to translate it into clinical practice " she said. She couldn't find her way out from beneath the avalanche of data.
 So she turned to Wong.
 Using his mathematical modeling  Wong sifted through Chang's data and the large databases of genome and clinical trial data. Out of that  he identified several candidate drugs to impair the genetic pathways that helped the cancer spread.
Chang's data and the large databases of genome and clinical trial data. Out of that  he identified several candidate drugs to impair the genetic pathways that helped the cancer spread.
 One of them  a drug named sunitinib  which treats a kidney cancer called renal cell carcinoma  emerged as the best bet. Chang then tested the drug in mice  and the study showed it prevented breast cancer from spreading to the brain.
 She has already begun a Phase II clinical trial of the drug  enrolling nine patients with metastatic breast cancer  and she is looking for more.
 "The drug is very well-tolerated by patients  and so far the trial is going very well " Chang said.
 But by using an existing drug  Chang and Wong could skip the lengthy Phase I  during which a drug is checked for safety. If Chang's tests go well  sunitinib could be on the market within a few years for metastatic breast cancer.
[EX A]:
IN OLD DRUGS RESEARCHER LOOKS FOR NEW TREATMENTS